- €44.26m
- €43.02m
- €66.65m
- 56
- 40
- 85
- 66
R2019 December 31st | 2020 December 31st | R2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 45.6 | 65.5 | 67.6 | 47.4 | 66.7 |
Cost of Revenue | |||||
Gross Profit | 21.5 | 28.8 | 25.9 | 7.25 | 19.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 47.2 | 64.9 | 60.3 | 59.9 | 64.6 |
Operating Profit | -1.57 | 0.683 | 7.37 | -12.5 | 2.09 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -2.16 | -0.347 | 7.03 | -12.6 | 1.64 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.38 | -0.066 | 6.08 | -12.1 | 2.86 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -2.37 | -0.003 | 2.97 | -15.8 | 0.762 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -2.37 | -0.003 | 2.97 | -2.86 | 0.762 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.072 | 0.01 | 0.243 | 0.127 | 0.116 |
Dividends per Share |